---
figid: PMC10341681__ijms-24-10505-g004
figtitle: Signaling pathways and targets of saponins against neuroinflammation in
  AD
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10341681
filename: PMC10341681__ijms-24-10505-g004.jpg
figlink: /pmc/articles/PMC10341681/figure/F4
number: F4
caption: The signaling pathways and targets of saponins against neuroinflammation
  in AD. (1). Theasaponin E1, CK, PGS, and AS-IV, regulate targets of NF-κB signaling
  pathway; (2). Dioscin, regulates targets of RAGE/NOX4 signaling pathway; (3). Platycodigenin,
  regulates targets of MAPK and NF-κB signaling pathways; (4). Ginsenoside Rg5, regulates
  targets of MAPK and PI3K/Akt signaling pathways; (5). PLD, regulates targets of
  TLR4/NF-κB signaling pathway; (6). NTR2, regulates targets of miR-27a/SOX8/β-catenin
  signaling pathways; (7). BF, AS-IV, Ginsenoside Rg1, Timosaponin BII, ginsenoside
  Rb1, and PF11, regulate various inflammatory factors, such as IL-16, IL-1β, etc.;
  (8). Ginsenosides Rd and hyo, enhance the expression of many anti-inflammatory factors,
  such as IL-10 and Hsp70, in addition to reducing inflammatory factors. The above
  saponins suppress neuroinflammation in AD through regulating targets of these signaling
  pathways
papertitle: 'Therapeutic Candidates for Alzheimer’s Disease: Saponins'
reftext: Ruifeng Zhang, et al. Int J Mol Sci. 2023 Jul;24(13).
year: '2023'
doi: 10.3390/ijms241310505
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: Alzheimer’s disease | saponin | amyloid beta | inflammation | oxidative
  stress | apoptosis
automl_pathway: 0.9101182
figid_alias: PMC10341681__F4
figtype: Figure
redirect_from: /figures/PMC10341681__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10341681__ijms-24-10505-g004.html
  '@type': Dataset
  description: The signaling pathways and targets of saponins against neuroinflammation
    in AD. (1). Theasaponin E1, CK, PGS, and AS-IV, regulate targets of NF-κB signaling
    pathway; (2). Dioscin, regulates targets of RAGE/NOX4 signaling pathway; (3).
    Platycodigenin, regulates targets of MAPK and NF-κB signaling pathways; (4). Ginsenoside
    Rg5, regulates targets of MAPK and PI3K/Akt signaling pathways; (5). PLD, regulates
    targets of TLR4/NF-κB signaling pathway; (6). NTR2, regulates targets of miR-27a/SOX8/β-catenin
    signaling pathways; (7). BF, AS-IV, Ginsenoside Rg1, Timosaponin BII, ginsenoside
    Rb1, and PF11, regulate various inflammatory factors, such as IL-16, IL-1β, etc.;
    (8). Ginsenosides Rd and hyo, enhance the expression of many anti-inflammatory
    factors, such as IL-10 and Hsp70, in addition to reducing inflammatory factors.
    The above saponins suppress neuroinflammation in AD through regulating targets
    of these signaling pathways
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AGER
  - MOK
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - MAPK8
  - MAPK9
  - MAPK10
  - NFKB1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - NOX4
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MIR27A
  - SOX8
  - CTNNB1
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - IL4
  - IL10
  - HSPA1A
  - HSPA4
  - CYBB
  - NOS1
  - PTGS2
  - IL6
  - NOS2
  - ISYNA1
  - TNF
  - MMP9
  - CDK2
  - AGES
  - Nucleus
---
